Seed Stage Showcase Presenters
Akeeko
Akeeko Medical is developing the Akeeko Stent Inserter™, a single-use device for ureteric stenting to relieve acute renal colic. It enables stent insertion outside the operating room (OR), faster pain relief, no general anaesthetic, greater procedural control, and the potential to free beds and save OR hours.
Athena Urologic, LLC
Athena Urologic is a medical device company focused on improving office-based management of women's urinary incontinence with the world's first 'female-friendly' cystoscope. Learn More
CareTech Human Inc.
Developed and launched in Ukraine, and now incubated at and supported by Cornell University, CareTech is dedicated to solving one of the most vexing challenges facing urologists–how to properly monitor and assess patient condition without frequent office visits. Learn More
Docology, LLC
Docology is an intelligent workflow automation layer between your fax infrastructure and EMR. We capture, parse, and organize inbound documents, create clean clinical summaries and timelines, and route everything directly into the patient chart—without altering your existing workflow. Learn More
Etta.io
Etta.io is a medical device and software company developing AI-powered tools to help specialists detect difficult-to-see cancers in real time. The company is co-founded by a Urologist, and an AI engineer. Our flagship urology product, Cysto.ai, assists urologists in detecting carcinoma in situ (CIS), a flat, high-grade bladder tumor often missed under standard white-light cystoscopy. Cysto.ai integrates advanced computer vision algorithms into a plug-and-play hardware unit that overlays heatmaps and natural language reasoning onto live endoscopic video. Learn More
Flowsient
Flowsient is a medical device startup dedicated to transforming home diagnostics through fluid mechanics. Our vision is to democratize uroflowmetry and bladder health monitoring, making it as simple and portable as checking blood pressure at home. Learn More
Genevi Technologies Inc
Genevi Technologies is a women's urologic medtech company founded by leading pelvic health experts to create a new, first-line category in urinary incontinence. Genevi is pioneering a breakthrough therapy designed to restore urethral closure pressure, the biological gateway to continence. Learn More
Genoplex.ai
Genoplex is a health technology company transforming how patients are identified, referred, and connected to advanced therapies, including CAR-T cell therapies, gene therapies, and radiopharmaceuticals, through its AI-orchestrated platform, Advanced Therapy Connect™. The company is on a mission to expand patient access to advanced therapies by modernizing the digital infrastructure connecting patients, providers, and treatment centers to reduce the time from diagnosis to treatment. Learn More
NIB Biotec
NIB biotec pioneers next-gen prostate cancer diagnostics with proprietary biomarker-based urine IVDs, delivering rapid, accessible, and cost-efficient tools that redefine early detection and streamline clinical decision-making. Learn More
Paterna Biosciences
Paterna Biosciences is the first end-to-end in vitro gametogenesis platform company, developing in vitrospermatogenesis (IVS) and ovarian follicle maturation technology to address male and female infertility. Paterna is enabling gametogenesis from spermatogonial stem cells and primordial follicles, which can help over 700M men and women around the world. Learn More
Paxos Medical Inc.
Paxos Medical is developing an implantable neuromodulation therapy for Underactive Bladder that replaces 4-6 daily self-catheterizations. Our target patient population has sensory and/or motor deficits that prevent the detrusor muscle from initiating and completing a void normally as a result of trauma, pelvic or gynecological surgery, spinal cord injuries, diabetes, aging, or other neurological disease. Our implantable neuromodulation system, UnderControlTM, provides on-demand bladder voiding. UnderControlTM is activated by the patient via a phone app to deliver 60 seconds of stimulation to nerves that are on either side of the proximal urethra, responsible for maintaining a void, to initiate and complete a void without the use of a catheter. Learn More
Proluma Medical Inc
Proluma Medical is developing a next generation Foley catheter for the fast growing and highly profitable billion-dollar premium Foley catheter market. Preclinical testing of Proluma’s patented catheter design demonstrated substantially reduced urethral trauma compared to a commercially available “lubricious” catheter. Learn More
SIPE LLC
The ECC Eagle™ is a novel, safe, breathable, leak-proof male external urine condom catheter. Reliable hold & removal because of its unique tacky-gel weave (USPTO No.: US 11,806,275B2; Nov. 7, 2023). No adhesives or clamps.
TOBY Oncology
TOBY Oncology uses an AI enabled non-invasive urine-based VOC test to accurately detect early stage (i.e. stages 1-2) cancers. Built on a decade of validated science and defensible IP, TOBY offers affordable, rapid screening and Minimal Residual Detection (MRD) with FDA Breakthrough Device designation. Learn More
Urologic Health
Urologic Health is transforming bladder diagnostics with a first-of-its-kind, fully external technology that measures bladder pressure, volume, and flow during natural filling, unlocking a new generation of cutting-edge, non-invasive bladder assessments. Learn More